Lupus Science And Medicine Podcast

Dr Jill Buyon, co-Editor in Chief of Lupus, Science & Medicine, explores the lessons we're learning six months into the global pandemic and the impact this is having on lupus patients, the medical landscape, and the research publishing space.

In the second part of a general update on the effects of Covid-19 in lupus patients, Sara Booth, University of Cambridge, talks to Dr Anca D Askanase, MD, MPH Director, Columbia University Lupus Center Associate Professor of Medicine Columbia University College of Physicians and Surgeons. Listen to part one on your favourite podcast provider, including one of the links below: https://soundcloud.com/bmjpodcasts/immunity-for-lupus-patients-and-effects-of-covid-19-part-1 Apple Podcasts: https://podcasts.apple.com/gb/podcast/lupus-science-and-medicine-podcast/id1023734925 Google Podcasts: https://podcasts.google.com/?feed=aHR0cDovL2ZlZWRzLmJtai5jb20vbHVwdXMvcG9kY2FzdHM&hl=en-GB

In this podcast, Sara Booth, University of Cambridge, talks to Professor Sarah Rowlands (Florey Professor of Infection and Immunity,University of Sheffield and Honorary Consultant Physician Nuffield Department of Medicine, Oxford), who specialises in infectious diseases and has a special interest in immunity to viruses. Listen to part two on your favourite podcast provider, including one of the links below: https://soundcloud.com/bmjpodcasts/lupus-immunity-and-covid-19-part-2 Apple Podcasts: https://podcasts.apple.com/gb/podcast/lupus-science-and-medicine-podcast/id1023734925 Google Podcasts: https://podcasts.google.com/?feed=aHR0cDovL2ZlZWRzLmJtai5jb20vbHVwdXMvcG9kY2FzdHM&hl=en-GB

An insight into the important learnings of the Lupus Academy 2017 is brought to you in this special Lupus Science & Medicine podcast. The Editor-in-Chief of the journal Ronald van Vollenhoven, a founding member of the Lupus Academy, spoke with several of the faculty and the delegates during the meeting held in Lisbon, Portugal, between the 5th and the 7th of May. The Lupus Academy is a UK-based not-for-profit organisation dedicated to providing high-quality education to medical specialists and trainees regarding Systemic lupus erythematosus (SLE). The 5th annual conference was attended by around 140 delegates from many different, mostly European countries, and the large international faculty produced an educational program. Highlights of the meeting include a debate session on the topic of "Mixed connective tissue disease - is the term archaic and should it be abandoned" where the side in favor of this proposal won a narrow victory; plenary lectures on a wide range of topics from the immunopathology o

To mark the first anniversary of Lupus Science and Medicine Harriet Vickers speaks to Dr Ronald van Vollenhoven and Dr Jill Buyon about notable published papers, publishing without an impact factor and what to expect from the journal in the coming year.

Sandra Raymond, president and CEO of the Lupus Foundation of America, talks about why the foundation wanted to create Lupus Science and Medicine, and what she hopes the journal will achieve. For more information on the journal, see http://journals.bmj.com/site/lupus/index.html.

The Lupus Foundation of America and BMJ are joining forces to publish Lupus Science and Medicine, the first open access lupus scientific journal. Joint editor-in-chief Ronald van Vollenhoven, also head of the Unit for Clinical Therapy Research, Inflammatory Diseases, Karolinska Institutet, discusses what readers and authors can expect from the journal. To sign up for updates about the journal, go to: http://journals.bmj.com/site/lupus/index.html